GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medistim ASA (OSTO:MEDIO) » Definitions » Gross Margin %

Medistim ASA (OSTO:MEDIO) Gross Margin % : 77.78% (As of Dec. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Medistim ASA Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Medistim ASA's Gross Profit for the three months ended in Dec. 2024 was kr117.6 Mil. Medistim ASA's Revenue for the three months ended in Dec. 2024 was kr151.1 Mil. Therefore, Medistim ASA's Gross Margin % for the quarter that ended in Dec. 2024 was 77.78%.


The historical rank and industry rank for Medistim ASA's Gross Margin % or its related term are showing as below:

OSTO:MEDIO' s Gross Margin % Range Over the Past 10 Years
Min: 74.14   Med: 77.16   Max: 79.79
Current: 79.79


During the past 13 years, the highest Gross Margin % of Medistim ASA was 79.79%. The lowest was 74.14%. And the median was 77.16%.

OSTO:MEDIO's Gross Margin % is ranked better than
90.55% of 804 companies
in the Medical Devices & Instruments industry
Industry Median: 52.415 vs OSTO:MEDIO: 79.79

Medistim ASA had a gross margin of 77.78% for the quarter that ended in Dec. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Medistim ASA was 0.40% per year.


Medistim ASA Gross Margin % Historical Data

The historical data trend for Medistim ASA's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medistim ASA Gross Margin % Chart

Medistim ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 78.50 76.76 78.10 78.45 79.56

Medistim ASA Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 74.83 81.33 80.02 80.30 77.78

Competitive Comparison of Medistim ASA's Gross Margin %

For the Medical Devices subindustry, Medistim ASA's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medistim ASA's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medistim ASA's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Medistim ASA's Gross Margin % falls into.


;
;

Medistim ASA Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Medistim ASA's Gross Margin for the fiscal year that ended in Dec. 2024 is calculated as

Gross Margin % (A: Dec. 2024 )=Gross Profit (A: Dec. 2024 ) / Revenue (A: Dec. 2024 )
=442.5 / 556.164
=(Revenue - Cost of Goods Sold) / Revenue
=(556.164 - 113.68) / 556.164
=79.56 %

Medistim ASA's Gross Margin for the quarter that ended in Dec. 2024 is calculated as


Gross Margin % (Q: Dec. 2024 )=Gross Profit (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=117.6 / 151.139
=(Revenue - Cost of Goods Sold) / Revenue
=(151.139 - 33.586) / 151.139
=77.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Medistim ASA  (OSTO:MEDIO) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Medistim ASA had a gross margin of 77.78% for the quarter that ended in Dec. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Medistim ASA Gross Margin % Related Terms

Thank you for viewing the detailed overview of Medistim ASA's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Medistim ASA Business Description

Traded in Other Exchanges
Address
Okernveien 94, Oslo, NOR, 0579
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing, and sales of medical equipment through its own business or participation in other companies, as well as related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, China, and the Rest of the World. The main divisions are sale of own products and sale of third-party products. Sale of own products has two business models, the capital model and the lease model. Third-party products segment sells medical devices from third party manufacturers in Norway, Sweden and Denmark. Key revenue is generated from Own Products segment.

Medistim ASA Headlines

No Headlines